Stephen M Kanovsky insider trades
Open-market stock purchases and sales by Stephen M Kanovsky, Director at Neogenomics Inc, from SEC Form 4 filings since Jun 6, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +113%.
Companies traded
- NEO Neogenomics Inc: 1 buy, last Jun 1, 2026